CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We keep our 12-month target price of $57, valuing DD shares at 22x our 2027 EPS estimate of $2.60 (raised by $0.11) and 24x our 2026 EPS estimate of $2.35 (raised by $0.07). Our target multiples compare to DD's three-year average forward multiple of 19x. DuPont reported impressive Q1 2026 results with adjusted EPS of $0.55 versus $0.36 in the prior year, beating consensus estimates of $0.48, while net sales rose 4% (beating our 3% forecast) with organic growth of 2% and operating EBITDA margins that expanded 230 bps to 24.6% from 22.3%. Operating cash flow more than tripled to $232M from $77M, and transaction-adjusted free cash flow surged to $147M from $8M Y/Y, with operating EBITDA rising 15% to $414M. We applaud these results, as DuPont delivered strong performance across all metrics while completing its strategic portfolio transformation, demonstrating pricing power with a 1% pricing contribution and significant margin expansion despite mixed end-market conditions.